Drug Profile
Paroxetine low-dose - Noven Therapeutics
Alternative Names: Brisdelle; LDMP; Low-dose mesylate salt of paroxetine; Mesafem; Paroxetine mesylateLatest Information Update: 05 Jan 2022
Price :
$50
*
At a glance
- Originator Synthon Pharmaceuticals Ltd
- Developer Noven Therapeutics
- Class Antidepressants; Anxiolytics; Benzodioxoles; Fluorobenzenes; Irritable bowel syndrome therapies; Piperidines; Small molecules
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Vasomotor symptoms
Most Recent Events
- 15 Oct 2014 Adverse events data from two phase III studies in Vasomotor symptoms released by Noven Pharmaceuticals
- 13 Jan 2014 Noven Pharmaceuticals and Shionogi agree to co-promote low-dose paroxetine in USA for Vasomotor symptoms
- 05 Nov 2013 Launched for Vasomotor symptoms in USA (PO) - first global launch